Crispr and Cas Gene Market, By Product Type, By Application, By End User, By Region

Description

The global crispr and cas gene market is estimated to be valued at US$ 1.54 Billion in 2023 and is expected to exhibit a CAGR of 22.8 % during the forecast period (2023-2030).

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 1.54 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	22.80%	2030 Value Projection:	US$ 6.47 Bn

Figure 1. Global Crispr and Cas Gene Market Share (%), By Product Type, 2023

Clustered Regularly Interspaced Short Palindromic Repeats is known as CRISPR. It is a DNA-chopping element of bacterial immune systems that has been transformed into a gene editing tool. By following a configurable guide, it functions as a precise pair of molecular scissors that can cut a target DNA sequence.

A guide RNA sequence (gRNA), which leads the Cas nuclease to its target, and a CRISPR-associated (Cas) nuclease, which binds and breaks DNA, are the two essential components of the system. It was found in bacterial immune systems, where it destroys bacteriophage-invading viruses-by chopping off their DNA. It was swiftly created as a tool for editing genomes after the molecular basis for its DNA-cleaving ability was identified.

CRISPR is significant because it enables researchers to change practically any organism's genetic coding. In comparison to earlier gene editing methods, it is easier, less expensive, and more accurate. It also has a variety of practical applications, including as developing crops that can withstand drought and correcting genetic diseases.

In bacteria and archaea, adaptive immunity is based on the CRISPR system. It makes use of Cas nucleases, enzymes that can attach to DNA and cause double-stranded breaks (DSBs). A protospacer, a segment of viral DNA, gets cut off by the Cas nuclease when a virus infects a bacteria. This fragment, along with others from earlier infected viruses, is kept in the bacterial genome as an immunological memory. The arrangement of spacers and palindromic repeats that results in the placement of these viral spacer pieces between repetitive sequences is what gives CRISPR its name.

Market Dynamics

The key players in the crispr and cas gene market are focusing on the development of innovative products is expected to propel the market growth over the forecast period. For instance, on February 8, 2023, Vertex Therapeutics, a biotechnology company, submitted its first CRISPR-based gene editing therapy to the U.S. Food and Drug Administration (FDA).

Key features of the study:

This report provides an in-depth analysis of the global crispr and cas gene market and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
The study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global crispr and cas gene market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
The key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA (Sigma-Aldrich), OriGene Technologies, Inc., New England Biolabs, Cellecta, Inc., Agilent Technologies, Inc., Applied StemCell, Inc., Synthego, Genscript, Mirus Bio LLC, Integrated DNA Technologies, Inc., and Mammoth Biosciences, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global crispr and cas gene market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global crispr and cas gene market

Global Crispr and Cas Gene Market Detailed Segmentation:

By Product Type:
- Vector-based Cas
- DNA-free Cas
- Others
By Application:
- Genome Engineering
- Disease Models
- Functional Genomics
- Knockdown/Activation
- Others
By End User:
- Biotechnology and Pharmaceutical Companies
- Academic & Government Research Institutes
- Contract Research Organizations
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles
- Thermo Fisher Scientific Inc.
- Merck KGaA (Sigma-Aldrich)
- OriGene Technologies, Inc.
- New England Biolabs
- Cellecta, Inc.
- Agilent Technologies
- Applied StemCell, Inc
- Synthego
- Genscript
- Mirus Bio LLC
- Integrated DNA Technologies, Inc.
- Mammoth Biosciences, Inc.

Product Code: CMI2598

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Recent Trends
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis
PORTER's Analysis

4. Global Crispr And Cas Gene Market - COVID-19 Impact Analysis

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Crispr And Cas Gene Market, By Product Type, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Vector-based Cas
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
DNA-free Cas
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends

6. Global Crispr And Cas Gene Market, By Application, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Genome Engineering
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Disease Models
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Functional Genomics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Knockdown/Activation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends

7. Global Crispr And Cas Gene Market, By End User, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Biotechnology and Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Academic & Government Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Contract Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)

8. Global Crispr And Cas Gene Market, By Region, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
North America
- Market Size and Forecast, Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By Application, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By End User, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
U.S.
Canada
Europe
- Market Size and Forecast, Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By Application, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By End User, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
- Market Size and Forecast, Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By Application, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By End User, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Market Size and Forecast, Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By Application, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By End User, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2018 - 2030, (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
- Market Size and Forecast, Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By Application, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By End User, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth, By Country/Region, 2018 -2030, (US$ Bn)
North Africa
Central Africa
South Africa

9. Competitive Landscape

Company Profiles
- Thermo Fisher Scientific Inc.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- Merck KGaA (Sigma-Aldrich)
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- OriGene Technologies, Inc.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- New England Biolabs
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- Cellecta, Inc.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- Agilent Technologies
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- Applied StemCell, Inc.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- Synthego
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- Genscript
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- Mirus Bio LLC
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- Integrated DNA Technologies, Inc.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- Mammoth Biosciences, Inc.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- Analysts' Views

10. Section

References
Research Methodology
About us and Sales Contact